Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Adicet Bio, Inc. Director's Dealing 2021

Jun 14, 2021

34412_dirs_2021-06-14_a4aa45dc-cf01-424d-bca6-9b42927ba6db.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Adicet Bio, Inc. (ACET)
CIK: 0001720580
Period of Report: 2021-06-11

Reporting Person: ABBOT STEWART (See Remarks)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-06-11 Non-Qualified Option (right to buy) $11.75 A 5000 Acquired 2031-06-10 Common Stock (5000) Direct

Footnotes

F1: The shares underlying this option shall vest in twelve equal monthly installments commencing on June 11, 2021.